Preprint · OA
via OpenAlex
Biological age measured by DNA methylation clocks and mortality: A systematic review and meta-analysis
Jian Hua Tay, Duarte Barros, Jiajun Dong, Shubham Choudhury, Austeja Bakulaite, Weilan Wang, Andrea Britta Maier
medRxiv · 2026
Abstract
Abstract This systematic review aimed to synthesize evidence on the association between DNA methylation (DNAm) age and all-cause and disease-specific mortality risks in adults. A systematic search of six databases from Jan 1 2011 to April 15 2026 identified articles assessing the association of DNAm age measures and all-cause or disease-specific mortality in adults from general or disease-specific populations. Effect sizes were pooled as hazard ratios (HRs) with 95% confidence intervals (CIs) using inverse-variance random-effects models. Of 42 023 records screened, 125 articles (380 705 participants) met the inclusion criteria, with 53 included in meta-analyses. Overall, 48 distinct DNAm clocks were evaluated. Higher DNAm ages were associated with higher risks of all-cause, cardiovascular, and cancer mortality risks. In general populations, GrimAge epigenetic age acceleration (EAA) showed consistent associations across mortality outcomes, with each 1 year higher GrimAge EAA associated with ∼6-10% higher all-cause (31 cohorts, n=53 642, HR per SD: 1.46 [95% CI 1.38, 1.55], HR per 1-year: 1.09 [95% CI 1.08, 1.11], I²=84.1%, p-value=1.21×10⁻¹⁴), cardiovascular (6 cohorts, n=30 751, HR per SD: 1.55 [95% CI 1.38, 1.73], HR per 1-year: 1.10 [95% CI 1.07, 1.13], I²=28.0%, p-value=1.71×10⁻⁴), and cancer (5 cohorts, n=27 187, HR per SD: 1.31 [95% CI 1.15, 1.50], HR per 1-year: 1.06 [95% CI 1.03, 1.10], I²=33.6%, p-value=4.76×10⁻³) mortality. Clocks incorporating additional surrogates and technical refinements showed numerically larger pooled associations than their original counterparts. GrimAge2 (HR per SD: 1.65 [95% CI 1.53, 1.77] vs 1.46 [1.38, 1.55]) and PCGrimAge (1.56 [1.36, 1.78] vs 1.51 [1.32, 1.74]) showed higher pooled HR association with all-cause mortality than GrimAge. Further work is warranted to evaluate the responsiveness of DNAm clocks to interventions and potential clinical utility.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.64898/2026.10.20.26365864
- Canonical
- link ↗
- Fetched
- 2026-10-25 MST
Cite this
APA
Tay, J.H., Barros, D., Dong, J., Choudhury, S., Bakulaite, A., Wang, W., & Maier, A.B. (2026). Biological age measured by DNA methylation clocks and mortality: A systematic review and meta-analysis. <em>medRxiv</em>. https://doi.org/10.64898/2026.10.20.26365864
Vancouver
Tay JH, Barros D, Dong J, Choudhury S, Bakulaite A, Wang W, et al. Biological age measured by DNA methylation clocks and mortality: A systematic review and meta-analysis. medRxiv. 2026. doi:10.64898/2026.10.20.26365864.
BibTeX
@unpublished{jian2026Biolog,
title = {Biological age measured by DNA methylation clocks and mortality: A systematic review and meta-analysis},
author = {Jian Hua Tay and Duarte Barros and Jiajun Dong and Shubham Choudhury and Austeja Bakulaite and Weilan Wang and Andrea Britta Maier},
journal = {medRxiv},
year = {2026},
doi = {10.64898/2026.10.20.26365864},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cancer Research 2024
Citation only
Abstract 7010: A pan-tissue investigation of epigenetic aging in association with genetic risk for cancer among European descendants
The Lancet Healthy Longevity 2026
Open access · CC-BY
Physical activity and biological age measured by DNA methylation clocks: a systematic review and meta-analysis
Mechanisms of Ageing and Development 2026
Open access · CC-BY
Biological age measured by DNA methylation clocks and reproductive history: Systematic review and meta-analysis
GeroScience 2026
Open access · CC-BY
Genetic predisposition to longer lifespan, lifestyle factors, and all-cause mortality: a 17-year prospective cohort study
2026
Preprint
Epigenetic signatures of biological vulnerability and residual risk in heart failure
bioRxiv (Cold Spring Harbor Laboratory) 2022
Preprint · CC-BY